Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: May 4, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | A | A | $907.21B | 941,741,406 | 84.21% | 10.57% | Net Selling | Net Buying |
| GILD | GILEAD SCIENCES INC | A | C | $163.43B | 1,241,420,528 | 87.89% | 1.12% | Net Selling | Net Selling |
| CAH | CARDINAL HEALTH INC | A | A | $45.73B | 234,205,855 | 88.71% | 4.21% | Net Selling | Net Selling |
| DXCM | DEXCOM INC | A | B | $23.67B | 385,872,977 | 94.92% | 4.73% | Net Selling | Net Selling |
| THC | TENET HEALTHCARE CORP | A | B | $15.79B | 86,137,000 | 31.79% | 68.21% | Net Selling | Net Selling |
| JLL | JONES LANG LASALLE INC | A | B | $14.63B | 46,393,575 | 94.93% | 2.93% | Net Selling | Net Selling |
| LEVI | LEVI STRAUSS & CO | A | A | $8.57B | 384,596,251 | 22.58% | 1.93% | Net Selling | Net Selling |
| BCO | BRINKS CO | A | C | $4.42B | 41,152,517 | 80.77% | 19.23% | Net Buying | Net Buying |
| AMRX | AMNEAL PHARMACEUTICALS INC | A | A | $4.04B | 314,629,101 | 29.21% | 70.79% | Net Selling | Net Selling |
| KTB | KONTOOR BRANDS INC | A | C | $3.99B | 55,254,141 | 97.17% | 2.83% | Net Selling | Net Selling |
| LIVN | LIVANOVA PLC | A | C | $3.34B | 54,689,876 | 90.73% | 9.27% | Net Selling | Net Selling |
| DBD | DIEBOLD NIXDORF INC | A | C | $2.70B | 34,628,392 | 84.75% | 15.25% | Net Selling | Net Selling |
| VCYT | VERACYTE INC | A | B | $2.63B | 79,458,427 | 66.85% | 33.15% | Net Selling | Net Selling |
| ATRO | ASTRONICS CORP | A | B | $2.54B | 35,691,175 | 71.62% | 28.38% | Net Selling | Net Buying |
| HLIO | HELIOS TECHNOLOGIES INC | A | C | $2.21B | 33,107,113 | 92.21% | 7.79% | Net Buying | Net Buying |
| HCI | HCI GROUP INC | A | B | $1.98B | 12,991,955 | 79.60% | 10.78% | Net Buying | Net Buying |
| INVA | INNOVIVA INC | A | B | $1.71B | 74,073,646 | 60.21% | 39.79% | Net Buying | Net Selling |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | A | A | $1.30B | 25,619,983 | 74.11% | 25.89% | Net Selling | Net Selling |
| PHAR | PHARMING GROUP NV | A | B | $1.19B | 701,680,440 | 0.02% | 0.00% | ||
| INR | INFINITY NATURAL RESOURCES INC | A | B | $1.03B | 63,413,674 | 22.24% | 77.76% | Net Selling | Net Selling |
| MNTN | MNTN INC | A | A | $749.07M | 73,872,710 | 41.57% | 20.69% | Net Selling | Net Buying |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | A | C | $628.04M | 37,316,546 | 13.22% | 60.71% | Net Buying | Net Buying |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | A | $466.75M | 17,507,608 | 22.35% | 77.65% | Net Selling | Net Buying |
| ASMB | ASSEMBLY BIOSCIENCES INC | A | B | $434.16M | 15,862,705 | 52.43% | 47.57% | Net Selling | Net Selling |
| PKOH | PARK OHIO HOLDINGS CORP | A | C | $410.95M | 14,399,130 | 52.47% | 40.00% | Net Selling | Net Selling |
| ELMD | ELECTROMED INC | A | A | $211.85M | 8,275,313 | 34.45% | 65.55% | Net Selling | |
| INFU | INFUSYSTEM HOLDINGS INC | A | A | $209.63M | 20,215,159 | 26.62% | 73.38% | Net Selling | Net Buying |
| PMTS | CPI CARD GROUP INC | A | C | $199.18M | 11,460,436 | 15.82% | 84.18% | Net Selling | Net Selling |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.